These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32949)

  • 1. Treatment of irritable bowel syndrome with lorazepam, hyoscine butylbromide, and ispaghula husk.
    Ritchie JA; Truelove SC
    Br Med J; 1979 Feb; 1(6160):376-8. PubMed ID: 32949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of various treatments for irritable bowel syndrome.
    Ritchie JA; Truelove SC
    Br Med J; 1980 Nov; 281(6251):1317-9. PubMed ID: 6254602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral hyoscine butylbromide for irritable bowel syndrome?
    MacRae KD
    Br Med J; 1979 Mar; 1(6165):752. PubMed ID: 435771
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral hyoscine butylbromide for irritable bowel syndrome?
    Gibbons D
    Br Med J; 1979 Mar; 1(6165):752. PubMed ID: 435769
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral hyoscine butylbromide for irritable bowel syndrome?
    Herxheimer A; Misiewicz JJ
    Br Med J; 1979 Mar; 1(6165):752. PubMed ID: 435770
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of mebeverine with high-fibre dietary advice and mebeverine plus ispaghula in the treatment of irritable bowel syndrome: an open, prospectively randomised, parallel group study.
    Chapman ND; Grillage MG; Mazumder R; Atkinson SN
    Br J Clin Pract; 1990 Nov; 44(11):461-6. PubMed ID: 2177997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimum dosage of ispaghula husk in patients with irritable bowel syndrome: correlation of symptom relief with whole gut transit time and stool weight.
    Kumar A; Kumar N; Vij JC; Sarin SK; Anand BS
    Gut; 1987 Feb; 28(2):150-5. PubMed ID: 3030900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double blind study of ispaghula in irritable bowel syndrome.
    Prior A; Whorwell PJ
    Gut; 1987 Nov; 28(11):1510-3. PubMed ID: 3322956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The treatment of irritable colon. Efficacy and tolerance of buscopan plus, buscopan, paracetamol and placebo in ambulatory patients with irritable colon].
    Schäfer E; Ewe K
    Fortschr Med; 1990 Aug; 108(25):488-92. PubMed ID: 2210587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of ispaghula husk in the management of irritable bowel syndrome (a randomized double-blind crossover study).
    Golechha AC; Chadda VS; Chadda S; Sharma SK; Mishra SN
    J Assoc Physicians India; 1982 Jun; 30(6):353-5. PubMed ID: 6302072
    [No Abstract]   [Full Text] [Related]  

  • 11. Emergency department management of undifferentiated abdominal pain with hyoscine butylbromide and paracetamol: a randomised control trial.
    Remington-Hobbs J; Petts G; Harris T
    Emerg Med J; 2012 Dec; 29(12):989-94. PubMed ID: 22307926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of effectiveness of 4-methylumbelliferone and hyoscine-N-butylbromide in therapy following biliary tract surgery].
    Fischer D; Krumme H
    Med Welt; 1980 Jun; 31(23):894-7. PubMed ID: 6775170
    [No Abstract]   [Full Text] [Related]  

  • 13. [Sodium diclofenac in the treatment of biliary pain: a controlled study using hyoscine N-butylbromide].
    Rossi PC; Giudicelli N; Parenti G; Pacetti E
    Clin Ter; 1988 Sep; 126(6):405-10. PubMed ID: 2974401
    [No Abstract]   [Full Text] [Related]  

  • 14. Routine use of hyoscine N butylbromide (Buscopan) in double contrast barium enema examinations.
    Lee JR
    Clin Radiol; 1982 May; 33(3):273-6. PubMed ID: 7075130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wheat fibre and irritable bowel syndrome. A controlled trial.
    Manning AP; Heaton KW; Harvey RF
    Lancet; 1977 Aug; 2(8035):417-8. PubMed ID: 70639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the therapeutic effect of wheat bran, mebeverine and placebo in patients with the irritable bowel syndrome.
    Kruis W; Weinzierl M; Schüssler P; Holl J
    Digestion; 1986; 34(3):196-201. PubMed ID: 3019810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral cimetropium bromide, a new antimuscarinic drug, for long-term treatment of irritable bowel syndrome.
    Centonze V; Imbimbo BP; Campanozzi F; Attolini E; Daniotti S; Albano O
    Am J Gastroenterol; 1988 Nov; 83(11):1262-6. PubMed ID: 3055943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different therapeutic regimens in irritable bowel syndrome.
    Nigam P; Kapoor KK; Rastog CK; Kumar A; Gupta AK
    J Assoc Physicians India; 1984 Dec; 32(12):1041-4. PubMed ID: 6526796
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of various treatments for irritable bowel syndrome.
    Nyhlin H; Eastwood M
    Br Med J (Clin Res Ed); 1981 Jan; 282(6257):74-5. PubMed ID: 6256034
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bran in the treatment of irritable colon. A double-blind controlled investigation].
    Soltoft J; Gudmand-Hoyer E; Krag B; Kristensen E; Wulff HR
    Ugeskr Laeger; 1976 Nov; 138(49):3316-8. PubMed ID: 793121
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.